PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.88%
Revenue growth 1.25-1.5x BIDU's 7.15%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
8.48%
Gross profit growth above 1.5x BIDU's 5.35%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
14.68%
EBIT growth above 1.5x BIDU's 3.19%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
14.68%
Operating income growth above 1.5x BIDU's 3.19%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-0.92%
Negative net income growth while BIDU stands at 9.14%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.32%
Share count expansion well above BIDU's 0.06%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.48%
Diluted share count expanding well above BIDU's 0.22%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-0.66%
Negative OCF growth while BIDU is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-9.08%
Negative FCF growth while BIDU is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
3997.74%
10Y revenue/share CAGR under 50% of BIDU's 14241.27%. Michael Burry would suspect a lasting competitive disadvantage.
206.93%
5Y revenue/share CAGR under 50% of BIDU's 1489.85%. Michael Burry would suspect a significant competitive gap or product weakness.
79.77%
3Y revenue/share CAGR under 50% of BIDU's 597.22%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
300.53%
5Y OCF/share CAGR at 50-75% of BIDU's 512.48%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
79.05%
3Y OCF/share CAGR of 79.05% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
4274.09%
Below 50% of BIDU's 30102.08%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
143.89%
Below 50% of BIDU's 1451.54%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
584.69%
3Y net income/share CAGR 75-90% of BIDU's 748.50%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
217.23%
Below 50% of BIDU's 981.27%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
99.40%
Below 50% of BIDU's 385.88%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.31%
AR growth of 5.31% while BIDU is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
5.05%
Asset growth of 5.05% while BIDU is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
5.70%
BV/share growth of 5.70% while BIDU is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
No Data
No Data available this quarter, please select a different quarter.
-7.34%
Our R&D shrinks while BIDU invests at 8.12%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
36.81%
SG&A growth well above BIDU's 13.52%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.